A novel prognostic signature based on four glycolysis-related genes predicts survival and clinical risk of hepatocellular carcinoma.
Zhihong ChenYiping ZouYuanpeng ZhangZhenrong ChenFan WuNing ShiHaosheng JinPublished in: Journal of clinical laboratory analysis (2021)
The gene signature may contribute to individual risk estimation, survival prognosis, and clinical management.